Abstract:Background Epitope prediction is a useful approach in cancer immunology and immunotherapy. Many computational methods, including machine learning and network analysis, have been developed quickly for such purposes. However, regarding clinical applications, the existing tools are insufficient because few of the predicted binding molecules are immunogenic. Hence, to develop more potent and effective vaccines, it is important to understand binding and immunogenic potential. Here, we observed that the interactive association constituted by human leukocyte antigen (HLA)-peptide pairs can be regarded as a network in which each HLA and peptide is taken as a node. We speculated whether this network could detect the essential interactive propensities embedded in HLA-peptide pairs. Thus, we developed a network-based deep learning method called DeepNetBim by harnessing binding and immunogenic information to predict HLA-peptide interactions. Results Quantitative class I HLA-peptide binding data and qualitative immunogenic data (including data generated from T cell activation assays, major histocompatibility complex (MHC) binding assays and MHC ligand elution assays) were retrieved from the Immune Epitope Database database. The weighted HLA-peptide binding network and immunogenic network were integrated into a network-based deep learning algorithm constituted by a convolutional neural network and an attention mechanism. The results showed that the integration of network centrality metrics increased the power of both binding and immunogenicity predictions, while the new model significantly outperformed those that did not include network features and those with shuffled networks. Applied on benchmark and independent datasets, DeepNetBim achieved an AUC score of 93.74% in HLA-peptide binding prediction, outperforming 11 state-of-the-art relevant models. Furthermore, the performance enhancement of the combined model, which filtered out negative immunogenic predictions, was confirmed on neoantigen identification by an increase in both positive predictive value (PPV) and the proportion of neoantigen recognition. Conclusions We developed a network-based deep learning method called DeepNetBim as a pan-specific epitope prediction tool. It extracted the attributes of the network as new features from HLA-peptide binding and immunogenic models. We observed that not only did DeepNetBim binding model outperform other updated methods but the combination of our two models showed better performance. This indicates further applications in clinical practice.

HLAB: Learning the BiLSTM Features from the ProtBert-encoded Proteins for the Class I HLA-peptide Binding Prediction.

MATHLA: a robust framework for HLA-peptide binding prediction integrating bidirectional LSTM and multiple head attention mechanism

HLA class I binding prediction via convolutional neural networks

Attention-Aware Contrastive Learning for Predicting Peptide-HLA Binding Specificity.

A comprehensive review and performance evaluation of bioinformatics tools for HLA class I peptide-binding prediction

TripHLApan: predicting HLA molecules binding peptides based on triple coding matrix and transfer learning

Machine learning application to predict binding affinity between peptide containing non-canonical amino acids and HLA0201

Predicting Binding-Peptide of HLA-I on Unknown Alleles by Integrating Sequence Information and Energies of Contact Residues.

A comprehensive assessment and comparison of tools for HLA class I peptide-binding prediction

Machine Learning Methods for Predicting HLA-Peptide Binding Activity.

Peptide-Major Histocompatibility Complex Class I Binding Prediction Based on Deep Learning with Novel Feature.

Integrating peptides' sequence and energy of contact residues information improves prediction of peptide and HLA-I binding with unknown alleles

Ranking-based Convolutional Neural Network Models for Peptide-MHC Binding Prediction

DapNet-HLA: Adaptive Dual-Attention Mechanism Network Based on Deep Learning to Predict Non-Classical HLA Binding Sites.

TlcMHCpan: A Novel Deep Learning Model for Enhanced Pan-Specific Prediction of Peptide-HLA Binding

DeepNetBim: Deep Learning Model for Predicting HLA-epitope Interactions Based on Network Analysis by Harnessing Binding and Immunogenicity Information

A novel kernel-based approach for predicting binding peptides for HLA class II molecules

CapHLA: a comprehensive tool to predict peptide presentation and binding to HLA class I and class II

Prediction of Major Histocompatibility Complex Binding with Bilateral and Variable Long Short Term Memory Networks

Improving Prediction of MHC Class I Binding Peptides with Additional Binding Data

Identification of the Core Regulators of the Hla I-Peptide Binding Process